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Abstract
Background: Although mepivacaine has a known biphasic action on the aortic and coronary artery in several
animal species, its effects on the lingual and pulmonary artery are not well understood and it is not yet known
whether mepivacaine produces vasoconstriction in these vessels. The present study aims to investigate the direct
effects of mepivacaine on swine lingual, pulmonary and coronary arterial endothelium-denuded rings.
Methods: Artery rings were perfused with isotonic 40 mM KCl until a stable constricted plateau was reached. The
rings were then perfused with isotonic 40 mM KCl plus a particular concentration of mepivacaine (0.4 μM, 4.0 μM,
40 μM, 0.4 mM and 4.0 mM). The isometric tension strengths in each experiment were normalized to the strength
of the isometric tension immediately before mepivacaine perfusion and expressed as a percentage.
Results: Mepivacaine at 0.4 to 40 μM did not significantly alter 40 mM KCl-induced contraction in the lingual,
pulmonary and coronary arterial rings. In contrast, mepivacaine at 4 mM produced attenuated vasoconstriction in
the lingual, pulmonary and coronary arterial compared with isotonic 40 mM KCl.
Conclusions: Mepivacaine produced vasoconstriction at lower concentrations, followed by attenuated vasoconstriction
at higher concentrations on swine lingual, pulmonary and coronary arterial endothelium-denuded rings. Mepivacaine
(4 μM) appeared to increase isotonic 40 mM KCl-induced contraction, followed by attenuated vasoconstriction at 4 mM.
Dentists using 3 % mepivacaine should take into consideration that the risk of complications may be increased if more
than six mepivacaine cartridges are used in dental treatment or minor surgery, or if over 15 ml of mepivacaine is
administered to a patient with cardiovascular complications during general anesthesia for oral maxillofacial surgery.
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Background
Amino-amide local anesthetics including mepivacaine,
lidocaine, ropivacaine and levobupivacaine have a biphasic
action on the smooth muscle of peripheral vessels, ranging
from vasoconstriction to vasodilation depending on the
concentration used [3, 11, 16]. Mepivacaine essentially has
mild vasoconstrictive activity in vessels [15]. Although
mepivacaine has a biphasic action on the aortic or coron-
ary artery in several animal species [12, 18, 20], there are
few studies examining the effects of mepivacaine on other
peripheral vessels, such as the craniofacial arteries or the
pulmonary artery.
Dentists typically use mepivacaine without vasocon-
strictors for short-duration dental procedures and oral
maxillofacial surgery. Regarding absorption rates and
blood kinetics of mepivacaine, the maximum concentra-
tion in plasma was 4.65 ± 0.47 μg/ml 15 min after ad-
ministration of 25 ml of 2 % mepivacaine to epidural
blocks, and 3.53 ± 0.39 μg/ml 25 min after administra-
tion of 25 ml of 2 % mepivacaine to peripheral nerve
brachial plexus blocks [19]. In dental treatment, mean
peak serum levels of 0.69 μg/ml were reached when one
dental cartridge (1.8 ml) containing 54 mg mepivacaine
was infiltrated at the mucosa on the apex of the right
maxillary second bicuspid, while the mean peak levels
were 1.31 μg/ml when two dental cartridges (3.6 ml)
containing a total of 108 mg mepivacaine were infil-
trated at the same mucosa [6]. The rate and degree of
diffusion is governed by the degree of plasma protein
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binding, the degree of ionization, and the degree of lipid
solubility. Local anesthetics appear to be inversely re-
lated to the degree of plasma protein binding, as only
the free, unbound drug is available; mepivacaine is ap-
proximately 77 % bound to plasma proteins [2]. The
most commonly encountered acute adverse experiences
which demand immediate countermeasures are related
to the central nervous system and the cardiovascular
systems. These adverse experiences are generally dose-
related and due to high plasma levels. In additional to
systemic dose-related toxicity, an intentional subarach-
noid injection of drug during the intended performance
of caudal or lumbar epidural block or nerve blocks near
the vertebral column may result in underventilation or
apnea. Toxic blood concentrations depress cardiac con-
duction and excitability, which may lead to atrioven-
tricular block and ultimately to cardiac arrest [17].
The effects of mepivacaine on local regions such as
craniofacial and pulmonary arteries are not well-known.
Mepivacaine has such a diversity of effects on smooth
muscle that we cannot guess its effects on any particular
smooth muscle. Although mepivacaine has a biphasic
action on the aortic or coronary artery in several animal
species, its effects on the lingual or the pulmonary artery
are not well understood. It has also not yet been fully
investigated whether mepivacaine produces vasocon-
striction in these vessels, and if mepivacaine does produce
vasoconstricion in these vessels, the concentrations produ-
cing vasoconstriction have not yet been determined. The
present study aims to clarify these issues. Thus, the
present study was designed to further investigate the dir-
ect effects of mepivacaine on these vessels in vitro using
swine lingual and pulmonary arterial rings and compared
with the coronary artery.
Methods
This study was approved by the Institutional Review
Committee on the Ethics of Animal Experiments of
Iwate Medical University. All experiments were con-
ducted in accordance with the Institutional Animals
Care and Use Committee guidelines.
Reagents and solutions
Mepivacaine hydrochloride was purchased from Sigma–
Aldrich Corp. (St. Louis, USA). All other chemicals were
obtained from Wako Pure Chemical Industries (Osaka,
Japan). In all experiments, air-equilibrated Hank’s bal-
anced salt solution (HBSS) was used to maintain the
arteries under resting conditions. HBSS was made up
of 137 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4,
1.26 mM CaCl2, 0.34 mM Na2HPO4, 0.44 mM
KH2PO4, 4.2 mM NaHCO3, and 5.55 mM glucose
(pH 7.34). All other salt solutions used as perfusate
were made by modifying HBSS. Isotonic 40 or 100 mM
KCl solution was prepared by replacing the NaCl in
the HBSS solution with an equimolar amount of KCl.
Each isotonic 40 mM KCl alone and isotonic 40 mM
KCl plus mepivacaine treatment was made by adding
the component agents into the isotonic 40 mM KCl
immediately before use.
Artery ring preparation and isometric tension
measurement
Fresh swine tongues, lungs and hearts were obtained
from a local abattoir. A segment of the lingual artery at
the proximal region of the tongue, third generation pul-
monary artery and left coronary artery was dissected
out. After the adventitia was removed, the lingual artery
and coronary artery segments (approximately 2 mm in
diameter) and the pulmonary artery segments (approxi-
mately 2–3 mm in diameter) were cut into 3-mm-long
rings, and the lumen surface was rubbed gently against a
thin arm of stainless steel tweezers to remove the endo-
thelium [7]. It was confirmed that 3 μM acetylcholine-
induced relaxation of the artery rings preconttracted
with 40 mM KCl. The artery rings were kept in HBSS at
5 °C until used for measurement.
An artery ring was held with two tungsten needles in
the perfusion chamber (containing 3 ml of perfusate).
One needle was fastened to a displacement transducer
(Type UL-2GR, Minebea Co., Fujisawa, Japan), and the
other to a micromanipulator. The solution was bubbled
with a mixture of 95 % O2 and 5 % CO2, and held at a
temperature of 37 °C and flow rate of 1.6 ml/min with a
peristaltic pump (SMP-23, Tokyo Rikakikai Co., Tokyo,
Japan). As the strength of contraction did not change
when the resting tone was 3–7 mN, the artery rings
were extended to give a resting tone of approximately 5
mN and immediately tested for contractility by two
2.5 min perfusions with isotonic 100 mM KCl separated
by a 10 min HBSS perfusion. After a 30 min HBSS per-
fusion, artery rings were perfused with isotonic 40 mM
KCl. When a stable constricted plateau was reached
with isotonic 40 mM KCl, an isotonic 40 mM KCl solu-
tion containing mepivacaine at concentrations of
0.4 μM, 4.0 μM, 40 μM, 0.4 mM and 4.0 mM was per-
fused. Each concentration was perfused for 5 min.
HBSS perfusion was always performed after all drug
perfusions were completed. Isometric tension was de-
tected using a displacement transducer, and signals de-
tected were amplified with a carrier amplifier (CSD-815
Digital indicator, Minebea Co., Fujisawa, Japan) and
recorded with a Powerlab 16/30 T data acquisition
system (ADInstruments, Bella Vista, Australia). The
isometric tension strengths in each experiment were
normalized to the strength of the isometric tension imme-
diately before mepivacaine perfusion. Vascular response
induced by mepivacaine in arterial rings was expressed as
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the percentage of the contraction induced by isotonic
40 mM KCl.
Statistical analyses
Dilation was determined by measuring the cumulative re-
duction in induced tone in the arterial segments, and was
expressed as the percentage of the contraction induced by
isotonic 40 mM KCl. A value of 0 % indicates initial rest-
ing tension (5 mN), and a value of 100 % indicates the iso-
metric tension generated by exposure to isotonic 40 mM
KCl. Values greater than 100 % indicate that contraction
occurred in response to mepivacaine. Values are presented
as mean ± standard deviation. Statistical analysis was per-
formed using SPSS, version 11.0 (SPSS, Chicago, IL, USA).
The Shapiro-Wilk test was used for normality, and
Bartlett’s test was used for homogeneity of variance.
Repeat measure analysis of variance (ANOVA) followed
by Bonferroni’s post-test was performed. Differences were
considered significant at P < .05.
Results
There was no response induced by mepivacaine in lingual,
pulmonary and coronary arterial rings under resting con-
ditions in HBSS (Fig. 1). Mepivacaine resulted in dilation
of the swine lingual, pulmonary and coronary arterial rings
that were maintained in a stable, constricted state; typical
traces of the changes in isometric tension in response to
increasing mepivacaine concentrations (0.4 μM to 4 mM)
are shown in Figs 2, 3 and 4. Dose response curves at
these concentrations are shown in Fig. 5. Mepivacaine
at 0.4 to 40 μM did not significantly alter 40 mM KCl-
induced contraction in the lingual, pulmonary and cor-
onary arterial rings (Table 1). In contrast, the highest
concentration of mepivacaine (4 mM) produced attenu-
ated vasoconstriction. There were significant differences
between the effects of the control solution (40 mM KCl)
and the effect of 4 mM mepivacaine on the lingual artery,
400 μM and 4 mM mepivacaine on the pulmonary artery,
and 4 mM mepivacaine on the coronary artery.
Discussion
Mepivacaine produced vasoconstriction at lower concen-
trations, followed by attenuated vasoconstriction at
higher concentrations on swine lingual, pulmonary and
coronary arterial endothelium-denuded rings under iso-
tonic conditions. Numerous studies have demonstrated
that amino-amide local anesthetic agents can exhibit
biphasic vascular effects, with contraction at low con-
centrations and decreased contraction or even dilation
at high concentrations reported in aortic or coronary
arterial rings in several animal species [4–6]. The biphasic
vascular effect is a common characteristic of amino-amide
local anesthetic agents that has been extensively studied
[1, 4, 10]. However, biphasic activity has been largely re-
ported in rat aortic or coronary arteries, and to our
knowledge there are no studies examining the effects of
mepivacaine on craniofacial arteries such as the lingual
artery. In this study, we found that mepivacaine appeared
Fig. 1 Effect of mepivacaine on arterial rings under resting conditions in Hank’s balanced salt solution. There was no response induced by
mepivacaine in lingual, pulmonary and coronary arterial rings
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to increase isotonic 40 mM KCl-induced contraction at
4 μM concentration, caused dilation at higher concen-
trations from 40 μM to 4 mM in the lingual and coron-
ary artery, and dose-dependent dilation from 40 μM to
4 mM in the pulmonary artery. We did not investigate
the mechanism(s) of smooth muscle constriction and
dilation by mepivacaine in this study. A previous report
investigating the effect of mepivacaine on the isolated
rat aorta found that verapamil and calcium-free Krebs
solution attenuated mepivacaine-induced contraction
of the endothelium-denuded aorta [16]. Thus, calcium
influx via voltage-operated calcium channel (VOCC)
activation by low concentrations of mepivacaine may
trigger the initial contraction, while a high concentra-
tion of mepivacaine had an inhibitory effect on the
VOCCs in vascular smooth muscle [16].
Mepivacaine (4 μM) appeared to increase isotonic
40 mM KCl-induced contraction, followed by attenuated
vasoconstriction at 4 mM compared with isotonic 40 mM
KCl-induced contraction. Similarly, a previous study found
that mepivacaine produced contraction at low concentra-
tions (1 × 10−3 and 3 × 10−3 mol/L) followed by dilation at
a high concentration (1 × 10−2 mol / L) in the rat aorta
[16]. It has been reported that contraction induced by KCl
and phenylephrine is attenuated in the presence of mepi-
vacaine (10−3 M) in isolated endothelium-denuded rat
aorta [10]. In contrast, lower concentrations of mepiva-
caine (10−9–10−5 M) did not evoke any changes in tension
in isolated ciliary artery rings [8]. Furthermore, it was
reported that in response to transmural stimulation, to
the tension of rabbit aortic strips was not altered by
mepivacaine in concentrations raging from 5 × 10−4 to
2 × 10−3 M [9]. In the present study, administration of
4.0 μM mepivacaine appeared to increase isotonic
40 mM KCl-induced contraction in swine lingual, pul-
monary and coronary arterial rings, which is a lower
concentration than those previously reported. The reasons

















Fig. 2 A typical trace showing the effect of mepivacaine on lingual artery ring contraction induced with 40 mM KCl. a Representative recording

















Fig. 3 A typical trace showing the effect of mepivacaine on pulmonary artery ring contraction induced with 40 mM KCl. a Representative
recording of the mepivacaine-induced contraction. b Enlarged view of a square portion of (a)
Satoh et al. BMC Anesthesiology  (2015) 15:101 Page 4 of 7
unknown, but may relate to differences in species and
location [16].
Our previous study suggested that lidocaine at low
concentrations produced vasoconstriction in swine lin-
gual and pulmonary arteries, while vasodilation was
seen at higher lidocaine concentrations of 1 μg/ml
[14]. Perlmutter reported that a lidocaine concentra-
tion of 10 μg/ml caused mild vasoconstriction in the
porcine coronary artery [12]. Therefore we used mepi-
vacaine at 0.4 μM, 4.0 μM, 40 μM, 0.4 mM and
4.0 mM concentrations as these are almost equivalent
to 0.11 μg/ml, 1.1 μg/ml, 11 μg/ml, 110 μg/ml, and
1,100 μg/ml concentrations.
The circulating levels of mepivacaine after dental in-
jections have been previously studied. Mean peak serum
levels of 0.69 μg/ml were reported when one dental cart-
ridge containing 54 mg mepivacaine was infiltrated at
the mucosa on the apex of the right maxillary second bi-
cuspid, while the mean peak levels were 1.31 μg/ml
when two dental cartridges containing 108 mg mepiva-
caine were infiltrated at the same mucosa [6]. It is thought
that the concentration of mepivacaine encountered in the
clinical setting is approximately 77 % protein-bound, and
the rest is free in plasma. If approximately 77 % of lido-
caine is bound to plasma proteins, we would assume that

















Fig. 4 A typical trace showing the effect of mepivacaine on coronary artery ring contraction induced with 40 mM KCl. a Representative recording
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* P<0.05 as compared with  the 






Fig. 5 Dose-dependent response of mepivacaine on lingual, pulmonary and coronary vasorelaxation. Endothelium-denuded lingual, pulmonary
and artery rings were challenged with a cumulative dose of mepivacaine. Tension was determined by isometric force transduction, and is
expressed as a percentage of the 40 mM KCl-induced contraction (N = 6). N indicates the number of arterial rings
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directly [2]. Hence, when one dental cartridge containing
54 mg mepivacaine is infiltrated into the mucosa, there
would presumably be mean peak levels of 0.16 μg/ml free
in plasma. In the present study, 4 μM (1.1 μg/ml) mepiva-
caine appeared to increase isotonic 40 mM KCl-induced
contraction in swine lingual, pulmonary and coronary ar-
terial rings. Thus, if we consider the amount of free
plasma mepivacaine when dentists infiltrate six to eight
dental mepivacaine cartridges into the oral mucosa,
mepivacaine-induced vasoconstriction may occur in the
orofacial, pulmonary and coronary arteries. An increase in
the plasma concentration of mepivacaine would increase
the concentration of free plasma mepivacaine. Therefore,
we think it is possible that mepivacaine-induced vasocon-
striction may occur in orofacial and pulmonary arteries
when less than six to eight mepivacaine cartridges are in-
filtrated into the oral mucosa. In dental treatment, we usu-
ally use one or two 3 % mepivacaine cartridges, but
occasionally more than six cartridges are used for minor
surgery or extraction. Dentists are educated to avoid using
lidocaine with adrenaline cartridges for patients with car-
diovascular complications, especially with a past history of
vasospasm, hypertension, and heart failure; therefore in
these patients local anesthetic without adrenaline is used,
for example mepivacaine or prilocaine with felypressin, to
prevent side effects induced by adrenaline. In patients with
cardiovascular complications, if more than six cartridges
of 3 % mepivacaine are used in dental treatment or minor
surgery, or over 15 ml at a time during general anesthesia
for oral maxillofacial surgery, this could potentially in-
crease the risks of complication by mepivacaine-induced
vasoconstriction in the lingual, coronary and pulmonary
arteries. In addition, mepivacaine-induced contraction
may be attenuated in patients taking calcium channel
antagonists for the management of hypertension, lead-
ing to a short duration of mepivacaine-induced anal-
gesia [13]. Mepivacaine-induced vasoconstriction may
contribute to pale skin color, decreased cutaneous
blood flow, attenuated capillary blood flow increase, at-
tenuated reactive hyperthermia observed after analgesia
induced by mepivacaine, and intermediate duration of
mepivacaine-induced analgesia [16].
There are some limitations to our study. Amino-amide
local anesthetics release nitric oxide, which produces
vasodilation of isolated vessels [3, 11, 16]; hence,
mepivacaine-induced vasoconstriction is attenuated in
endothelium-intact vessels compared with endothelium-
denuded vessels. As we used endothelium-denuded arterial
rings in the current study, mepivacaine-induced vasocon-
striction would be attenuated in an in vivo vessel with
its endothelium intact. In addition, the data in this
study are based on n = 6, which by all accounts is a
small sample size. However, despite the small sample
size and insufficient power analysis, we believe that the
data provide accurate and reliable information on the
effect of mepivacaine on arterial rings, and the findings
are useful for further investigation of craniofacial arteries.
Further research needs to be done to investigate whether
our in vitro results correlate with real-life situations.
Conclusions
This study showed that a low concentration of mepiva-
caine produced vasoconstriction, followed by attenuated
vasoconstriction at higher concentrations on swine lin-
gual, pulmonary and coronary arterial endothelium-
denuded rings. It also showed that mepivacaine (4 μM)
appeared to increase isotonic 40 mM KCl-induced con-
traction, followed by attenuated vasoconstriction at 4 mM
compared with isotonic 40 mM KCl-induced contraction.
Thus, dentists should consider that the risks of general
complications are potentially increased if more than six
cartridges of 3 % mepivacaine are used in dental treatment
or minor surgery, or over 15 ml of mepivacaine is used at
a time for a patient with cardiovascular disease during
general anesthesia for oral maxillofacial surgery.
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40 mM KCl 100 100 100
0.4 98.3 ± 1.4 98.3 ± 1.2 99.0 ± 0.9
4 108.2 ± 2.6 105.1 ± 2.6 103.1 ±
1.1
40 96.6 ± 6.4 98.1 ± 3.0 98.0 ± 4.6
400 90.6 ± 4.6 85.8 ± 5.2* 90.0 ± 6.8
4000 66.1 ±
10.2*
58.5 ± 5.0* 74.1 ± 8.2*
Data are mean ± SD. Values are expressed as the percentage of contraction
induced by isotonic 40 mM KCl
*P<0.05 as compared with the 40 mM KCl-induced contraction
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